(Q51998597)

19 April 2018

title

CD40 antibody as an adjuvant induces enhanced T cell responses. (English)

1 reference

19 April 2018

author name string

Jennifer Carlring

1

1 reference

19 April 2018

Tom A Barr

2

1 reference

19 April 2018

Adele L McCormick

3

1 reference

19 April 2018

Andrew W Heath

4

1 reference

19 April 2018

language of work or name

English

0 references

publication date

1 September 2004

1 reference

19 April 2018

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

19 April 2018

volume

22

1 reference

19 April 2018

issue

25-26

1 reference

19 April 2018

page(s)

3323-3328

1 reference

19 April 2018

Adjuvants for human vaccines--current status, problems and future prospects

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.043

Different T helper cell subsets elicited in mice utilizing two different adjuvant vehicles: the role of endogenous interleukin 1 in proliferative responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.043

Towards the rational design of Th1 adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.043

The danger model: a renewed sense of self

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.043

Proteins and their derived peptides as carriers in a conjugate vaccine for Streptococcus pneumoniae: self-heat shock protein 60 and tetanus toxoid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.043

Toll-like receptors as adjuvant receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.043

Cutting edge: impaired Toll-like receptor expression and function in aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.043

Fortifying B cells with CD154: an engaging tale of many hues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.043

Functions of CD40 on B cells, dendritic cells and other cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.043

Enhancement of T cell-independent immune responses in vivo by CD40 antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.043

A potent adjuvant effect of CD40 antibody attached to antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.043

Monoclonal antibodies to murine CD40 define two distinct functional epitopes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.043

Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.043

Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.043

Defining protective responses to pathogens: cytokine profiles in leprosy lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.043

Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.043

Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.043

Enhanced in vivo immune responses to bacterial lipopolysaccharide by exogenous CD40 stimulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.043

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2004.02.043

1 reference

19 April 2018

1 reference

19 April 2018